moxalactam has been researched along with azlocillin in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (75.00) | 18.7374 |
1990's | 1 (5.00) | 18.2507 |
2000's | 3 (15.00) | 29.6817 |
2010's | 1 (5.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Castanheira, M; Samuelsen, Ø; Spencer, J; Walsh, TR | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Blaser, J | 1 |
Blaser, J; Zinner, SH | 1 |
Marks, MI; Parker, KM; Stutman, HR | 1 |
Jehl, F; Monteil, H | 1 |
Albanese, J; Condomines, M; De Micco, P; Gouin, F; Mallet, MN | 1 |
Andrew, JH; Dixson, S | 1 |
Hofstra, H; van der Waaij, D; Wiegersma, N | 1 |
Baker, CN; Jones, RN; Thornsberry, C | 1 |
LeFrock, JL; Miller, MA; Vercler, MJ | 1 |
Weinstein, AJ | 1 |
Labthavikul, P; Neu, HC | 1 |
Traub, WH | 1 |
Agostini, M; Barlocco, G; Bonomi, U; Borgo, G; Bozzino, L; Cabrini, G; Cappelletti, LM; Castellani, L; Conforti, M; Mastella, G | 1 |
Calderwood, SB; Jackson, E; Tung, CC | 1 |
Creger, RJ; Falkowski, AJ | 1 |
Borner, K; Dzwillo, G; Koeppe, P; Lode, H; Madey, V | 1 |
1 trial(s) available for moxalactam and azlocillin
Article | Year |
---|---|
Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
Topics: Adolescent; Alcohol Deterrents; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Cephalosporins; Child; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Eosinophilia; Humans; Moxalactam; Penicillins; Piperacillin; Pseudomonas Infections; Random Allocation; Respiratory Tract Infections | 1983 |
19 other study(ies) available for moxalactam and azlocillin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
Topics: Acremonium; Bacterial Proteins; beta-Lactamases; Catalysis; Catalytic Domain; Cefepime; Ceftazidime; Cephalosporins; Kinetics; Models, Molecular; Mutation; Penicillinase; Protein Structure, Tertiary; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interactions of antimicrobial combinations in vitro: the relativity of synergism.
Topics: Amikacin; Azlocillin; Ceftazidime; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Escherichia coli; Imipenem; Klebsiella pneumoniae; Moxalactam; Netilmicin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus | 1990 |
In-vitro studies of antibiotic combinations with special emphasis on the evaluation of newly developed methods.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Ceftazidime; Drug Combinations; Drug Synergism; Escherichia coli; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Netilmicin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Thienamycins | 1986 |
Potential of moxalactam and other new antimicrobial agents for bilirubin-albumin displacement in neonates.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Bilirubin; Binding Sites; Cefoperazone; Ciprofloxacin; Enoxacin; Humans; Imipenem; In Vitro Techniques; Infant, Newborn; Moxalactam; Naphthyridines; Quinolines; Serum Albumin; Thienamycins | 1985 |
[Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
Topics: Anti-Bacterial Agents; Azlocillin; Cefoperazone; Ceftazidime; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas; Ticarcillin | 1987 |
A rapid high-performance liquid chromatography method for determining beta-lactam antibiotics in biological fluids and tissues.
Topics: Anti-Bacterial Agents; Azlocillin; Cefmenoxime; Chromatography, High Pressure Liquid; Humans; Moxalactam; Respiratory Tract Infections; Superinfection | 1987 |
The in vitro activity of the newer beta-lactam antibiotics against 124 strains of gram-negative bacilli.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Cephalosporins; Enterobacteriaceae; Gentamicins; Imipenem; Microbial Sensitivity Tests; Moxalactam; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Ticarcillin | 1985 |
Effect of beta-lactam antibiotics of the resistance of the digestive tract of mice to colonization.
Topics: Animals; Anti-Bacterial Agents; Azlocillin; beta-Lactams; Cefuroxime; Cephamycins; Dose-Response Relationship, Drug; Enterobacter; Enterobacteriaceae; Enterococcus faecalis; Escherichia coli; Feces; Female; Intestines; Mezlocillin; Mice; Moxalactam; Penicillins | 1982 |
In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
Topics: Azlocillin; beta-Lactamases; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Haemophilus influenzae; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins | 1980 |
Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
Topics: Azlocillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Imipenem; Lactams; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin; Serratia marcescens | 1981 |
The new cephalosporins and penicillins.
Topics: Azlocillin; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Mezlocillin; Moxalactam; Penicillins; Piperacillin | 1982 |
Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam.
Topics: Anti-Bacterial Agents; Azlocillin; Bacteria; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Drug Synergism; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillins | 1982 |
Agar (disk) diffusion test susceptibility of clinical isolates of Pseudomonas aeruginosa to azlocillin, cefotaxime, cefsulodin, lamoxactam, mezlocillin, and piperacillin.
Topics: Azlocillin; Cefotaxime; Cefsulodin; Cephalosporins; Cephamycins; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1982 |
Measurement of levels of aminoglycosides and vancomycin in serum in the presence of new beta-lactam antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Humans; Immunoenzyme Techniques; Mezlocillin; Moxalactam; Penicillins; Piperacillin; Vancomycin | 1984 |
Hydroxylamine technique for in vitro prevention of penicillin inactivation of tobramycin.
Topics: Azlocillin; Carbenicillin; Cefamandole; Drug Interactions; Humans; Hydroxylamine; Hydroxylamines; Immunoenzyme Techniques; In Vitro Techniques; Moxalactam; Penicillins; Piperacillin; Ticarcillin; Tobramycin | 1984 |
Serum bactericidal activity and kinetics of azlocillin and moxalactam after single and combined administration.
Topics: Adult; Azlocillin; Blood Bactericidal Activity; Chromatography, High Pressure Liquid; Drug Interactions; Enterobacteriaceae; Enterococcus faecalis; Female; Humans; Kinetics; Male; Middle Aged; Moxalactam; Penicillins; Pseudomonas aeruginosa | 1983 |